SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Raymond James increased their Q3 2025 earnings per share estimates for SNC-Lavalin Group in a research report issued to clients and investors on Wednesday, February 19th. Raymond James analyst F. Bastien now anticipates that the company will post earnings of $0.79 per share for the quarter, up from their previous estimate of $0.77. Raymond James also issued estimates for SNC-Lavalin Group’s Q4 2025 earnings at $0.81 EPS, FY2025 earnings at $2.85 EPS, Q1 2026 earnings at $0.72 EPS, Q3 2026 earnings at $0.98 EPS, Q4 2026 earnings at $0.82 EPS and FY2026 earnings at $3.40 EPS.
Separately, Stifel Canada upgraded shares of SNC-Lavalin Group to a “strong-buy” rating in a research report on Tuesday, February 4th.
SNC-Lavalin Group Stock Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
See Also
- Five stocks we like better than SNC-Lavalin Group
- How to Profit From Value Investing
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- ESG Stocks, What Investors Should Know
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- What does consumer price index measure?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
